Evidence map›Paper›PMID 26631476›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Parallel Inhibition of Dopamine Amacrine Cells and Intrinsically Photosensitive Retinal Ganglion Cells in a Non-Image-Forming Visual Circuit of the Mouse Retina.

Helen E Vuong, Claudia N Hardi, Steven Barnes, Nicholas C Brecha

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Advances in the study of ARR3 in myopia.Frontiers in cell and developmental biology · 2025
    Review
  3. Article
  4. Dopamine enhances GABAJournal of neurophysiology · 2024
    Article
  5. Article
  6. Dopamine enhances GABAbioRxiv : the preprint server for biology · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effects of Mydriatics on Rod/Cone- and Melanopsin-driven Pupil Responses.Optometry and vision science : official publication of the American Academy of Optometry · 2020
    Article
  16. Circadian regulation in the retina: From molecules to network.The European journal of neuroscience · 2020
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Helen E VuongDepartments of Neurobiology and Molecular, Cellular, and Integrative Physiology, Stein Eye Institute, and.
Claudia N HardiDepartments of Neurobiology and.
Steven BarnesDepartments of Neurobiology and Departments of Physiology and Biophysics and Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia B3H 4R2, Canada, and Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, California 90073.
Nicholas C BrechaDepartments of Neurobiology and Molecular, Cellular, and Integrative Physiology, Stein Eye Institute, and CURE: Digestive Diseases Research Center, David Geffen School of Medicine at UCLA, University of California Los Angeles, Los Angeles, California 90095, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, California 90073 nbrecha@ucla.edu.
Institute of Neurobiology · BGDalhousie University · CAVA Greater Los Angeles Healthcare System · US

Funding

Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
NEUROCHEMICAL PATHWAYS IN THE INNER RETINAR01EY004067 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRECHA, NICHOLAS C. · 1985 to 2019
$9.0M
Vision Science Training ProgramT32EY007026 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Alapakkam P Sampath · 1985 to 2026
$5.7M
BLRD VA IK6 BX005230CIHR MOP-10968NEI NIH HHS R01 EY004067NEI NIH HHS R01 EY04067NEI NIH HHS T32 EY007026NIDDK NIH HHS P30 DK041301NIDDK NIH HHS P30 DK41301
6 · The paper itself

Abstract

An inner retinal microcircuit composed of dopamine (DA)-containing amacrine cells and melanopsin-containing, intrinsically photosensitive retinal ganglion cells (M1 ipRGCs) process information about the duration and intensity of light exposures, mediating light adaptation, circadian entrainment, pupillary reflexes, and other aspects of non-image-forming vision. The neural interaction is reciprocal: M1 ipRGCs excite DA amacrine cells, and these, in turn, feed inhibition back onto M1 ipRGCs. We found that the neuropeptide somatostatin [somatotropin release inhibiting factor (SRIF)] also inhibits the intrinsic light response of M1 ipRGCs and postulated that, to tune the bidirectional interaction of M1 ipRGCs and DA amacrine cells, SRIF amacrine cells would provide inhibitory modulation to both cell types. SRIF amacrine cells, DA amacrine cells, and M1 ipRGCs form numerous contacts. DA amacrine cells and M1 ipRGCs express the SRIF receptor subtypes sst(2A) and sst4 respectively. SRIF modulation of the microcircuit was investigated with targeted patch-clamp recordings of DA amacrine cells in TH-RFP mice and M1 ipRGCs in OPN4-EGFP mice. SRIF increases K(+) currents, decreases Ca(2+) currents, and inhibits spike activity in both cell types, actions reproduced by the selective sst(2A) agonist L-054,264 (N-[(1R)-2-[[[(1S*,3R*)-3-(aminomethyl)cyclohexyl]methyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxoethyl]spiro[1H-indene-1,4'-piperidine]-1'-carboxamide) in DA amacrine cells and the selective sst4 agonist L-803,087 (N(2)-[4-(5,7-difluoro-2-phenyl-1H-indol-3-yl)-1-oxobutyl]-L-arginine methyl ester trifluoroacetate) in M1 ipRGCs. These parallel actions of SRIF may serve to counteract the disinhibition of M1 ipRGCs caused by SRIF inhibition of DA amacrine cells. This allows the actions of SRIF on DA amacrine cells to proceed with adjusting retinal DA levels without destabilizing light responses by M1 ipRGCs, which project to non-image-forming targets in the brain.

Indexed as

Amacrine CellsAmidesAnimalsCalciumDopamineExcitatory Amino Acid AgentsGABA AgentsIndolesIn Vitro TechniquesMelanopsinMiceMice, Inbred C57BLMice, TransgenicNerve Tissue ProteinsNeural InhibitionPhotic StimulationAmidesCalciumDopamineExcitatory Amino Acid AgentsGABA AgentsIndolesL 54264L803087MelanopsinNerve Tissue ProteinsPiperidinesRod OpsinsSomatostatinamacrine cellsdopamineinterneuronmelanopsin ipRGCsmicrocircuitsomatostatin

Identifiers

PMID26631476
PMCPMC4666919
OpenAlexW2184794175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.